𝔖 Bobbio Scriptorium
✦   LIBER   ✦

495 Pharmacological profile of the novel pan-CDK inhibitor BAY 1000394 in tumor models of human small cell lung cancer, breast and prostate cancer as monotherapy and combination treatment

✍ Scribed by G. Siemeister; A. Wengner; U. Lücking; P. Lienau; W. Steinke; C. Schatz; D. Mumberg; K. Ziegelbauer


Book ID
119603178
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
48 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.